Oncology Institute Share Holder Equity 2020-2025 | TOI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Oncology Institute share holder equity from 2020 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Oncology Institute share holder equity from 2020 to 2025. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$136B
CVS Health (CVS)	$78.4B
Elevance Health (ELV)	$62.4B
Cencora (COR)	$56.8B
DiDi Global (DIDIY)	$26.9B
Labcorp Holdings (LH)	$20.4B
Natera (NTRA)	$19B
BioMerieux (BMXMF)	$16.9B
EUROFINS SCIENT (ERFSF)	$14B
CochLear (CHEOY)	$13.1B
Solventum (SOLV)	$12.7B
ICON (ICLR)	$11.6B
Revvity (RVTY)	$11B
Viatris (VTRS)	$10.4B
Avantor (AVTR)	$9.1B
Medpace Holdings (MEDP)	$9B
Sonic Healthcare (SKHHY)	$8.9B
HealthEquity (HQY)	$8.4B
Caris Life Sciences,�Inc (CAI)	$7.7B
Charles River Laboratories (CRL)	$7.6B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$4.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.1B
Surgery Partners (SGRY)	$2.9B
Concentras Parent (CON)	$2.5B
Organon (OGN)	$2.5B
Alignment Healthcare (ALHC)	$2.5B
GeneDx Holdings (WGS)	$2.2B
Progyny (PGNY)	$1.9B